Скачать или смотреть 2015 04 02 14 01 Examining hepatitis C virus treatment access A review of select state Medicaid fee

The arrival of an HCV cure is an exciting development for the millions of Americans who suffer from HCV. However, the high cost of treatment has led many Medicaid programs across the country to implement treatment access restrictions. The restrictions unfairly limit access and are not based on clinical evidence. Action must be taken!

This webinar presented by Center for Health Law and Policy Innovation of Harvard Law School, the National Viral Hepatitis Roundtable, and HIV Health Reform provided information on a new report that analyzes treatment access restrictions in Medicaid fee-for-service and managed care programs across 10 states. Watch this webinar to learn how to utilize this tool to expand access to the cure in your state.

Presenters include:
Robert Greenwald, Director, Center for Health Law and Policy Innovation; Clinical Professor of Law, Harvard Law School
Kellen Wittkop, Harvard Law School
Ryan Clary, Executive Director, National Viral Hepatitis Roundtable
Michael Ninburg, Executive Director, Hepatitis Education Project